Purple Biotech (PPBT) Research & Development (2014 - 2026)

Purple Biotech (PPBT) has reported Research & Development for 12 consecutive years, with $702000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 26.94% year-over-year to $702000.0 in Q2 2026; TTM through Jun 2026 was $4.3 million, a 39.4% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, down 51.04% from the prior year.
• Research & Development was $702000.0 for Q2 2026 at Purple Biotech, down from $1.2 million in the prior quarter.
• Over five years, Research & Development peaked at $6.0 million in Q1 2022 and troughed at $458000.0 in Q4 2024.
• A 5-year average of $2.6 million and a median of $2.2 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development slumped 91.26% in 2024 and soared 299.34% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $4.8 million in 2022, then advanced by 8.76% to $5.2 million in 2023, then tumbled by 91.26% to $458000.0 in 2024, then soared by 299.34% to $1.8 million in 2025, then plunged by 61.62% to $702000.0 in 2026.
• The last three Research & Development figures came in at $702000.0 (Q2 2026), $1.2 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.